Get started
MASIMO CORPMASIMO CORPMASIMO CORP

MASIMO CORP

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Forecast

1MASI trade ideas

$MASI yieahhhMay be long term play to 360s but short term to the small wave 3 isn't too bad. I know I ain't patient, neeeiiiihh. If you are patient and like it, this set up has some good confluences that I like. 1. Big Wave 2 on .78 fib, looking also like the head of a big bull SHS structure. 2. Smaller Wave (2) bouncing on .61 fib which was also on the bottom of the trend it has been on this year. Same trend I am waiting to see if it breaks or does another test of the .61 before getting my toe on it. 3. Wave (2) looks like the second shoulder on the SHS. 4. SHS and 100% extension of (1) both take wave (3) to the same spot, same spot that has some fib confluences with the big 1 and 2 waves, same spot that has some previous resistance and supports. Ok enough with these confluences. Enjoy yieahh
NASDAQ:MASILong
by rubfigue
1
Masimo (NASDAQ:MASI) Stock's EvaluationMasimo (NASDAQ:MASI) has had a rough three months with its share price down 29%. We, however decided to study the company's financials to determine if they have got anything to do with the price decline. Long-term fundamentals are usually what drive market outcomes, so it's worth paying close attention. Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Simply put, it is used to assess the profitability of a company in relation to its equity capital. Why Is ROE Important For Earnings Growth? We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company’s earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don’t share these attributes. Masimo's Earnings Growth And 8.9% ROE At first glance, Masimo's ROE doesn't look very promising. Yet, a closer study shows that the company's ROE is similar to the industry average of 9.1%. Having said that, Masimo's net income growth over the past five years is more or less flat. Remember, the company's ROE is not particularly great to begin with. Hence, this provides some context to the flat earnings growth seen by the company. Next, on comparing with the industry net income growth, we found that the industry grew its earnings by 8.1% over the last few years. Is Masimo Making Efficient Use Of Its Profits? Masimo doesn't pay any dividend, meaning that potentially all of its profits are being reinvested in the business. However, this doesn't explain why the company hasn't seen any growth. It looks like there might be some other reasons to explain the lack in that respect. For example, the business could be in decline. Summary In total, am ambivalent about Masimo's performance. While the company does have a high rate of profit retention, its low rate of return is probably hampering its earnings growth. With that said, we studied the latest analyst forecasts and found that while the company has shrunk its earnings in the past, analysts expect its earnings to grow in the future
NASDAQ:MASILong
by DEXWireNews
1
MASI Insider OwnershipCEO has been buying shares since November 2022 - December 2022 setting up for 8.4% of insider ownership. Masimo has a market cap or net worth of $7.78 billion. The enterprise value is $8.52 billion.The stock price has decreased by -49.94% in the last 52 weeks. The beta is 0.88, so Masimo's price volatility has been lower than the market average. In the last 12 months, Masimo had revenue of $1.75 billion and earned $170.85 million in profits. Earnings per share was $3.02. Looking for a long term trend as it puts in this box.
NASDAQ:MASILong
by GlennTrading
Masimo Corp (NASDAQ: $MASI) In Store For A Lovely Bounce ❤️Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. The company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. The company offers coronavirus-2019 response and telehealth solutions; connectivity devices; and nasal high flow ventilation and neuromodulation solutions. The company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, physician offices, long term care facilities, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. Incorporated in 1989, the company is headquartered in Irvine, California.
NASDAQ:MASILong
by RedHotStocks
$MASI building 7 month #breakout baseA very constructive base building on NASDAQ:MASI for the last 7 months. * Decreasing volume during the base construction (Bullish) * Multiple candle stick demand tails in the last 7 months points to institutions stepping in to pick up more shares on any weakness (indicates demand to the stock even at these higher levels is well and strong). A strong daily close above $258 will signal the completion of the pattern and should set the stage to higher prices into uncharted territories.
NASDAQ:MASILong
by TaPlot
$MASI can fall in the next daysContextual immersion trading strategy idea. Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price in the next days. So I opened a short position from $218,41; stop-loss — $221,56. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:MASIShort
by KozakHlib
2